Catalyst Pharmaceuticals, Inc. (CPRX) ownership: Top institutional holder: BlackRock, Inc. ($464.86M). Insider activity: Net Seller (1 buys, 2 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 18774530.00 | $464.86M | 2026-03-31 |
| VANGUARD GROUP INC | 8432247.00 | $196.81M | 2025-12-31 |
| STATE STREET CORP | 6863060.00 | $169.93M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5122666.00 | $126.84M | 2026-03-31 |
| AMERICAN CENTURY COMPANIES INC | 4138416.00 | $102.47M | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3943600.00 | $97.64M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 3429615.00 | $84.91M | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 3036546.00 | $75.18M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-02-17 | |
| Buy | null | 2026-02-17 | |
| Sell | null | 2026-02-17 |
Back to CPRX overview · CPRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.